Abstract: Three simple protocols for the extraction of acyclovir from its pharmaceutical creams based on ultrasonication, ultrasonication with heating and magnetic stirring were evaluated and compared. Extraction kinetics were studied at different time intervals (5, 10, 15, 30 and 60 min) and the extraction efficiency was determined by HPLC. The effect of concentration of aqueous NaOH as the extraction medium and the stirring speed were also studied and optimized. Best results were obtained with 50 mL of 0.01 mol L -1 aqueous NaOH with magnetic stirring speed of 500 r.p.m. HPLC analysis involved rapid separation of acyclovir from the cream matrix using a 100 × 4.6 mm i.d. monolithic column and UV detection at 254 nm. Magnetic stirring produced the best results in terms of extraction efficiency with an average extraction yield of 100.8%, n = 16 at an optimum extraction time of 15 min. The selected protocol was validated for within and day-to-day precision and ruggedness.
Introduction
Sample preparation is a critical step in chemical analysis since it may introduce errors and inaccuracies in quantitative assays. An ideal sample preparation protocol should be simple, cost effective, fast and reproducible. Especially in pharmaceutical quality control, sample preparation must ensure rapid, quantitative and selective extraction of the active pharmaceutical ingredient (API) from the formulation (usually tablet, capsule or cream) and excipients used. Another significant feature is the possibility of parallel multi-sample pretreatment, in order to reduce total analysis time when a large number of samples have to be assayed e.g. during new product development or validation of the manufacturing process in the pharmaceutical industry.
Acyclovir ( Fig. 1) is an antiviral drug found in both tablets and creams that slows the growth and spread of the herpes virus so that the body can fight off the infection [1] . Acyclovir does not cure herpes. It reduces pain and helps the sores caused by the infection to heal faster. Some doctors even use acyclovir, along with other drugs, in the treatment of HIV [2] . Mild common side effects may be diarrhea, nausea, vomiting, itching and skin rash, while more serious side effects include hematuria, encephalopathic changes and elevation of serum creatinine [3] .
Messer and Taylor have reported the quantitative extraction of acyclovir from a pharmaceutical cream matrix of 5% w/w Zovirax ® using inverse analytical supercritical fluid extraction [4] . Although quite effective, the proposed sample preparation procedure is rather complicated requiring specialized instrumentation and strictly controlled conditions, therefore, being unattractive for routine quality control in an industrial environment.
The present study reports the results from the experimental evaluation of three protocols for the extraction of acyclovir from a pharmaceutical cream matrix of 5% w/w Hagevir ® cream (lot 004, Cosmopharm Ltd, Korinthos, Greece). The protocols are based on an alkaline extraction medium of 0.01 mol L -1 NaOH using one of the following: ultrasonication, ultrasonication with heat or magnetic stirring-based extraction . The protocols were evaluated and compared in terms of extraction time, efficiency and repeatability. Additional validation experiments of the selected protocol included day-to-day precision and ruggedness.
Recovery of acyclovir from the cream matrix was determined by an HPLC method based on monolithiccolumn separation and UV detection [5] . Monolithic columns, which have become commercially available recently [6, 7] , allow efficient separations at higher flow rates and lower back-pressures than conventional particulate-based columns. Such systems have already proven to have useful features for a number of applications in the pharmaceutical industry [5, [8] [9] [10] . Necessary re-validation experiments were carried-out in order to ensure the efficiency of the HPLC procedure for its intended purpose.
Experimental

Reagents
All reagents were of analytical grade and were provided by Merck, Germany; unless stated otherwise. HPLC mobile phase consisted of 0.2% v/v CH 3 COOH. HPLC grade water was used throughout this work. aqueous NaOH. The stock solution was stable for at least one week if kept refrigerated and protected from light. Working solutions of acyclovir were prepared by appropriate dilutions of the stock solution in 0.01 mol L -1 aqueous NaOH. It should be noted that the reported acyclovir concentrations are calculated on an anhydrous basis. Since acyclovir may contain up to 6% of water, it is necessary to determine its exact water content by KarlFischer titration and make the appropriate corrections.
A 1.0 mol L -1 aqueous NaOH stock solution was prepared by dissolving 40.0 g of NaOH pellets in 1.0 L of de-ionized water. 0.01 mol L -1 aqueous NaOH working solution was prepared by 100-fold dilution of the stock solution in HPLC-grade water.
All the pharmaceutical excipients for the synthesis of a placebo cream (all excipients excluding the API, viz, propylene glycol, sodium lauryl sulfate, paraffin soft white, paraffin liquid, cetostearyl alcohol and poloxamer 407) used in the accuracy studies were purchased from domestic suppliers.
Apparatus
An HP 1100 HPLC instrument (Hellamco S.A., Greece) was used throughout this study. It comprised of a quaternary pump, a vacuum degasser, a column thermostat, an autosampler and a DAD spectrophotometric detector. Chromatograms and chromatographic parameters (peak areas, retention times, S/N ratio etc) were recorded and calculated respectively via the Chem Station ® software. A RP-18e, monolithic 100 × 4.6 mm i.d. Chromolith ® Performance column (Merck, Germany) was used for separation of acyclovir.
A vacuum filtration system (Schleicher and Schuell, Germany) and 0.45 μm membrane filters (RC 55, Schleicher & Schuell, Germany) were used for the filtration of the mobile phase.
A Mettler-Toledo DL-18 Karl Fischer titrator (Hellamco S.A., Greece) was used for the determination of the water content of acyclovir in both the working standard and the raw material.
A model 19H ultrasonic bath (Ney-ultrasonics, US) and a model HI190M magnetic stirrer (Hanna Instruments Hellas, Greece) equipped with Teflon coated magnets (20 × 3 mm) were used throughout this study. In order to obtain steady conditions, the ultrasonic bath was operated for one hour prior to use. 
HPLC procedure
The standards and/or samples from the extraction procedures -20 μl in all cases-were injected into the monolithic column via the autosampler of the HPLC instrument. The flow rate was set at 2.0 mL min -1 in the range 0-1.50 min and at 5.0 mL min -1 in the range 1.51-3.00 min. The column temperature was 25°C, and peak area was used for signal evaluation. All standards and samples were injected in triplicates [5] .
Extraction protocols
Accurately weighed amounts of acyclovir-containing cream (100 ± 10 mg each) were dispersed in 50 mL of 0.01 mol L -1 aqueous NaOH. The theoretically expected acyclovir mass concentration is ca. 100 mg L -1 . Samples were processed via either ultrasonication associated with and without heating at 50°C or magnetic stirring at 500 r.p.m. for 5, 10, 15, 30 and 60 min intervals. Five different samples were used representing each extraction time. 
Results and Discussion
Analytical characteristics of the HPLC method
Operation of the HPLC system under the conditions described in [5] enables fast elution of acyclovir at ca. 2.40 min and effective separation from its major impurity guanine. The peaks were sharp and the baseline stable in all cases. However, some re-validation experiments were performed in order to ensure consistency and effectiveness of the HPLC procedure for quantification of acyclovir at lower concentration levels.
The linearity of an HPLC assay intended for pharmaceutical quality control is usually validated in the range of 80 -120% of the expected concentration of the API [5, 11] . Since the purpose of the present work was to study the extraction of acyclovir from the sample matrix, it was necessary to re-validate the linearity of the assay in the significantly more extended range of 0 -120% (n = 8; γ (acyclovir) = 5, 10, 20, 50, 70, 90, 100 and 120 mg L -1 ). The experiments confirmed the linearity of the method in the range studied, with a regression coefficient of 0.9999. Validation of the regression line was performed by the response factor (R.F.) test [12] . The deviation of the R.F. from the calibration curve must be within ± 3% of the experimental slope and is given by the equation:
The experimental results conform to the above mentioned limit (± 3%). The deviations of all points on the calibration curve of acyclovir were in the range of -2.4 to + 2.8% of the slope in the corresponding regression equation. The detection (LOD) and quantitation limits (LOQ) were estimated using the S/N criteria and were adequate for studying the extraction of acyclovir from the cream matrix, namely 0.05 mg L -1 (S/N = 3) and 0.15 mg L -1 (S/N = 10) respectively [5] . The precision of the assay was re-validated at three lower concentration levels compared to [5] , namely at 5, 10 and 50 mg L -1 of acyclovir. The relative standard deviations (n = 12) were excellent in all cases, being 1.4, 1.1 and 0.7% respectively.
The accuracy of the HPLC method was re-validated in the range of 5 -120 mg L -1 acyclovir. 100 mg of a placebo cream (40.0% propylene glycol, 0.75% 12.5% sodium lauryl sulfate, 12.5% paraffin soft white, 5.0% paraffin liquid, 6.75% cetostearyl alcohol and 1.0% poloxamer 407) were dispersed in 50 mL of 0.01 mol L -1 NaOH and spiked with acyclovir standard solution to final concentrations of 5, 10, 50, 100 and 120 mg L -1 . The results for three samples constructed at each concentration level are shown in Table 1 .
Evaluation of the extraction procedures
Hagevir ® cream (5.0% w/w acyclovir, Lot 004, Cosmopharm Ltd, Korinthos, Greece) was used for the evaluation of the extraction protocols, according to the experimental procedures described previously. The results for the ultrasonic (with and without heating) and magnetic stirring extraction processes are tabulated in Table 2 , while a graphical comparison is shown in Fig. 2 . Representative chromatograms of an acyclovir standard and a pharmaceutical cream sample are depicted in Fig. 3 . The experimental results clearly showed that acyclovir can be extracted quantitatively and reproducibly peak area intercept R.F.
[acyclovir] γ − = within 10 min by simple magnetic stirring. On the other hand, ultrasonication required 60 min for quantitative extraction and the reproducibility was poor. The combination of ultrasonication with simultaneous heating at 50°C did not result in significant improvement in the extraction yield. Fifteen minutes of extraction with magnetic stirring was selected as optimal for further experiments.
Optimization of magnetic stirring based extraction
Effect of the amount of NaOH concentration
The effect of the concentration of aqueous NaOH used as extraction medium was studied in the range of 0.001 -0.05 mol L -1 . The experimental results are depicted in Fig. 4 . Quantitative extraction of acyclovir was achieved for NaOH concentrations higher than 0.005 mol L -1 . 0.01 mol L -1 NaOH was selected as the optimal concentration for further studies.
Effect of stirring speed
The effect of stirring speed on the extraction efficiency was studied in the range of 100 -1000 r.p.m. 
Validation of extraction based on magnetic stirring
The optimum extraction procedure selected viz. 15 min of magnetic stirring at 500 r.p.m. using 0.01 mol L -1 aqueous NaOH as extraction medium was validated for within and for day-to-day precision and ruggedness.
Within and day-to-day precision
Eight extraction experiments were carried out at one hour intervals during a working day (within-day precision), while two experiments per day were carried out for a period of four consecutive working days (day-to-day precision). All samples from the day-to-day experiments were filtered and refrigerated in dark on completion of the experiment and and analyzed together as a sample set in order to avoid additional day-to-day variations from the HPLC assay. The experimental results were satisfactory in all cases and had within-and day-to- day RSDs of 3.1% and 4.7% respectively. The mean extraction yield of all experiments was 100.8%.
Ruggedness of the extraction procedure
The ruggedness of the extraction protocol was validated by small deliberate variations of critical parameters affecting the procedure around the optimal values. The extraction time was varied in the range of 12-18 min, the concentration of the extractant in the range of 0.008-0.012 mol L -1 and the stirring speed in the range of 400-600 r.p.m.. The experimental results are shown in Table 3 . No significant effect on the extraction yield was observed verifying the ruggedness of the selected extraction protocol.
Conclusions
Magnetic stirring proved superior to the ultrasonicbased procedures for the extraction of acyclovir from pharmaceutical creams both, in terms of rapidity and precision. Optimization and validation experiments confirmed that acyclovir could be extracted quantitatively from the cream matrix within 15 min in 0.01 mol L -1 NaOH at 500 r.p.m., while the within and day-to-day precision and ruggedness of the protocol were excellent in all cases. Compared with the procedure proposed by Messer and Taylor based on supercritical fluid extraction [4] , the proposed methodology is equally effective, much simpler and attractive to routine quality control of pharmaceutical formulations. The evaluated extraction protocol is currently being successfully applied to the quality and stability control of acyclovir in 5% w/w Hagevir ® cream at the facilities of Cosmopharm Ltd. 
